Breakthrough in fight against Hendra virus

Oct 30, 2009
Breakthrough in fight against Hendra virus
An artificially coloured transmission electron micrograph of Hendra virus. (CSIRO)

(PhysOrg.com) -- There has been a breakthrough in the fight against the deadly Hendra virus following the development of a treatment which shows great potential to save the lives of people who become infected with the virus.

A scientific team from CSIRO and the US has demonstrated that administering human monoclonal after exposure to Nipah virus, which is closely related to Hendra virus, protected animals from challenge in a disease model.

According to CSIRO's Dr Deborah Middleton, who led the experiments at Australia's maximum biosecurity facility, CSIRO's Australian Animal Health Laboratory (AAHL) in Geelong, said the findings are extremely encouraging.

"Our research clearly suggests that an effective treatment for Hendra virus infections in humans should be possible, given the very strong cross-reactive activity this antibody has against ," she said.

Antibodies - proteins found in blood or other bodily fluids of vertebrates - are used by the immune system to identify and neutralise bacteria and viruses.

First identified in Brisbane and isolated by CSIRO scientists in 1994, Hendra , which spreads from flying foxes, has regularly infected horses in Australia. Of the 12 equine outbreaks, four have led to human infection, with four of the seven known human cases being fatal, the most recent of these in September 2009. Human infection results from close contact with the blood and/or mucus of infected horses.

Dr Middleton said the success of the antibody will probably depend on dose and time of administration.

"As Hendra and Nipah viruses cause severe disease in humans, a successful application of this antibody as a post-exposure therapy will likely require early intervention.

"To make clinical use of it against these viruses, it will need to be prepared under proper manufacturing guidelines, carefully evaluated again in animal models and safety tested for human use. We hope this demonstration of antiviral activity will lead to some immediate activities to facilitate further development for its use in humans," Dr Middleton said.

The results of this latest research, conducted in collaboration with scientists from the US's Uniformed Services University of the Health Sciences, National Cancer Institute and the National Institutes of Health in the US, were published today in the journal PLoS Pathogens.

More information: dx.plos.org/10.1371/journal.ppat.1000642

Provided by CSIRO (news : web)

Explore further: Queuing theory helps physicist understand protein recycling

add to favorites email to friend print save as pdf

Related Stories

Minimising the spread of deadly Hendra virus

Mar 31, 2009

(PhysOrg.com) -- CSIRO Livestock Industries' scientists working at the Australian Animal Health Laboratory (AAHL), in Geelong Victoria, have made a major breakthrough in better understanding how Hendra spreads ...

Scientists Develop Vaccine Against Deadly Viruses

Oct 04, 2006

Scientists from the Uniformed Services University of the Health Sciences (USU), in collaboration with counterparts from the Australian Animal Health Laboratory (AAHL), have developed a vaccine to fight two deadly animal viruses ...

Discovery could be key to bioterrorism defense

Jul 30, 2005

A collaborative research team from the Uniformed Services University of the Health Sciences (USU), the Australian Animal Health Laboratory (AAHL) and the National Cancer Institute (NCI) have made a major breakthrough in efforts ...

Drug blocks two of world's deadliest emerging viruses

Mar 05, 2009

Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell ...

New reovirus isolated

Jun 27, 2007

CSIRO scientists have played a key role in discovering that bats are the likely host of a new virus that can cause a serious but apparently non-fatal respiratory tract illness in humans.

Recommended for you

Queuing theory helps physicist understand protein recycling

17 hours ago

We've all waited in line and most of us have gotten stuck in a check-out line longer than we would like. For Will Mather, assistant professor of physics and an instructor with the College of Science's Integrated Science Curriculum, ...

Cow manure harbors diverse new antibiotic resistance genes

Apr 22, 2014

Manure from dairy cows, which is commonly used as a farm soil fertilizer, contains a surprising number of newly identified antibiotic resistance genes from the cows' gut bacteria. The findings, reported in mBio the online ...

Researchers successfully clone adult human stem cells

Apr 18, 2014

(Phys.org) —An international team of researchers, led by Robert Lanza, of Advanced Cell Technology, has announced that they have performed the first successful cloning of adult human skin cells into stem ...

User comments : 0

More news stories

Rainbow trout genome sequenced

Using fish bred at Washington State University, an international team of researchers has mapped the genetic profile of the rainbow trout, a versatile salmonid whose relatively recent genetic history opens ...

New critter discovered on whale carcass

A new species of bug, similar in appearance to the common woodlouse, has been found plastered all over a whale carcass on the floor of the deep Southern Ocean.

Mantis shrimp stronger than airplanes

(Phys.org) —Inspired by the fist-like club of a mantis shrimp, a team of researchers led by University of California, Riverside, in collaboration with University of Southern California and Purdue University, ...

Volitional control from optical signals

(Medical Xpress)—In their quest to build better BMIs, or brain-machine-interfaces, researchers have recently begun to look closer at the sub-threshold activity of neurons. The reason for this trend is that ...